Literature DB >> 18802710

Neurofibromatosis type 1 and infantile spasms.

Martino Ruggieri1, Paola Iannetti, Maurizio Clementi, Agata Polizzi, Gemma Incorpora, Alberto Spalice, Piero Pavone, Andrea Domenico Praticò, Maurizio Elia, Anna Lia Gabriele, Romano Tenconi, Lorenzo Pavone.   

Abstract

BACKGROUND: There is no agreement on the prevalence, natural history and outcome of infantile spasms (IS) in neurofibromatosis type 1 (NF1). By contrast, its prevalence and outcome are well characterised in the setting of other neurocutaneous disorders (e.g. tuberous sclerosis).
MATERIALS AND METHODS: The aim of the present study was to try to establish a genotype-phenotype correlation in IS in the setting of NF1. A retrospective (years 1990-2000) and prospective (years 2000-2006) study in three paediatric centres in Italy were taken as referral populations for: (1) children with NF1 and (2) neurological problems in childhood.
RESULTS: Ten NF1 patients have had IS. The calculated population-based: (1) prevalence of IS in NF1 (0.76%) was higher than the reported frequency of IS in the general population (0.02-0.05%) and (2) frequency of NF1 in the IS series in two out of three centres (0.62-0.90%) was lower than the estimated frequencies in the literature (1.5-3.0%). Patients had psychomotor delay preceding the spasms (50%), symmetrical spasms (50%), typical (80%) and modified (20%) hypsarrhythmia and foci of spikes and waves and a good response to corticosteroid treatment (50%). Outcome was good in 30%. Imaging revealed high-signal foci in atypical locations (sub-cortical and central brain regions). Deoxyribonucleic acid analysis revealed three novel NF1 gene mutations without genotype-phenotype correlation.
CONCLUSION: Even though the combination of IS and NF1 does not seem to be coincidental, it is certainly an unusual event in NF1--rarer than in other neurocutaneous disorders. Spasms in NF1 are not associated with specific genetic defects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802710     DOI: 10.1007/s00381-008-0706-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  24 in total

Review 1.  The different forms of neurofibromatosis.

Authors:  M Ruggieri
Journal:  Childs Nerv Syst       Date:  1999-07       Impact factor: 1.475

2.  West syndrome and Lennox-Gastaut syndrome: a survey of natural history.

Authors:  T Kurokawa; N Goya; Y Fukuyama; M Suzuki; T Seki; S Ohtahara
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

Review 3.  [Natural evolution of neurocutaneous syndrome in adults].

Authors:  A Pou Serradell
Journal:  Rev Neurol       Date:  1996-09       Impact factor: 0.870

4.  Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

Authors:  M H Cnossen; K G Moons; M P Garssen; N M Pasmans; A de Goede-Bolder; M F Niermeijer; D E Grobbee
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

Review 5.  Child neurology in the 20th century.

Authors:  Stephen Ashwal; Robert Rust
Journal:  Pediatr Res       Date:  2003-02       Impact factor: 3.756

6.  Epidemiology of infantile spasms in Sweden.

Authors:  R Sidenvall; O Eeg-Olofsson
Journal:  Epilepsia       Date:  1995-06       Impact factor: 5.864

7.  Neurofibromatosis type one and West syndrome: a relatively benign association.

Authors:  J Motte; C Billard; N Fejerman; Z Sfaello; H Arroyo; O Dulac
Journal:  Epilepsia       Date:  1993 Jul-Aug       Impact factor: 5.864

8.  Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy.

Authors: 
Journal:  Epilepsia       Date:  1981-08       Impact factor: 5.864

9.  [Relationship between child epilepsy and MRI findings in von Recklinghausen neurofibromatosis (NF 1)].

Authors:  H Yasujima; M Komatsu; T Sakurai; S Kodama
Journal:  No To Hattatsu       Date:  1994-01

Review 10.  Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.

Authors:  M T Mackay; S K Weiss; T Adams-Webber; S Ashwal; D Stephens; K Ballaban-Gill; T Z Baram; M Duchowny; D Hirtz; J M Pellock; W D Shields; S Shinnar; E Wyllie; O C Snead
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

View more
  11 in total

Review 1.  The genetics of the epilepsies.

Authors:  Christelle M El Achkar; Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 2.  Genetic and biologic classification of infantile spasms.

Authors:  Alex R Paciorkowski; Liu Lin Thio; William B Dobyns
Journal:  Pediatr Neurol       Date:  2011-12       Impact factor: 3.372

3.  Therapeutics for childhood neurofibromatosis type 1 and type 2.

Authors:  Simone L Ardern-Holmes; Kathryn N North
Journal:  Curr Treat Options Neurol       Date:  2011-12       Impact factor: 3.598

4.  Epilepsy in NF1: a systematic review of the literature.

Authors:  Pia Bernardo; Giuseppe Cinalli; Claudia Santoro
Journal:  Childs Nerv Syst       Date:  2020-07-01       Impact factor: 1.475

Review 5.  Natural history of neurofibromatosis type 2 with onset before the age of 1 year.

Authors:  Martino Ruggieri; Anna Lia Gabriele; Agata Polizzi; Vincenzo Salpietro; Francesco Nicita; Piero Pavone; Nunzio Platania; Pietro Milone; Angela Distefano; Giuseppe Privitera; Giuseppe Belfiore; Francesca Granata; Rosario Caltabiano; Vincenzo Albanese; Lorenzo Pavone; Aldo Quattrone
Journal:  Neurogenetics       Date:  2013-02-03       Impact factor: 2.660

Review 6.  Modeling epileptic spasms during infancy: Are we heading for the treatment yet?

Authors:  Libor Velíšek; Jana Velíšková
Journal:  Pharmacol Ther       Date:  2020-05-15       Impact factor: 12.310

Review 7.  Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target.

Authors:  Aristea S Galanopoulou; Jan A Gorter; Carlos Cepeda
Journal:  Epilepsia       Date:  2012-05-11       Impact factor: 5.864

8.  Rapid ictal transition of focal epilepsy to infantile spasms in neurofibromatosis type 1 captured with EEG.

Authors:  Shital H Patel; Robert P Carson; Lori C Jordan; Lindsay M Pagano
Journal:  Epilepsy Behav Rep       Date:  2020-06-08

Review 9.  West syndrome: a comprehensive review.

Authors:  Piero Pavone; Agata Polizzi; Simona Domenica Marino; Giovanni Corsello; Raffaele Falsaperla; Silvia Marino; Martino Ruggieri
Journal:  Neurol Sci       Date:  2020-08-22       Impact factor: 3.307

10.  Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2.

Authors:  Satoshi Akamine; Noriaki Sagata; Yasunari Sakai; Takahiro A Kato; Takeshi Nakahara; Yuki Matsushita; Osamu Togao; Akio Hiwatashi; Masafumi Sanefuji; Yoshito Ishizaki; Hiroyuki Torisu; Hirotomo Saitsu; Naomichi Matsumoto; Toshiro Hara; Akira Sawa; Shinichi Kano; Masutaka Furue; Shigenobu Kanba; Chad A Shaw; Shouichi Ohga
Journal:  Epilepsia Open       Date:  2017-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.